Context: The aberrant expression or alternation of miRNA in the pathogenesis of aldosteroneproducing adenomas (APAs) is still largely unknown.
overproduction. Recent studies have shown that APAs with KCNJ5 somatic mutations occur in 40% to 60% of patients with APAs and that somatic mutations could play an important role in aldosterone production (2) (3) (4) . Further somatic mutations in a subunit of an L-type voltage-gated Ca 2+ -channel, Cav1.3 (encoded by CACNA1D), in 2 ATPases (Na + /K + -ATPase a-subunit and Ca 2+ -ATPase 3 encoded by ATP1A1 and ATP2B3, respectively), with stabilized b-catenin and increased AXIN2 expression encoded by CTNNB1 (5, 6) and in a voltage-gated chloride channel, ClC-2, encoded by CLCN2 (7) were identified recently.
The Wnt/b-catenin pathway plays an important role in the regulation of cell proliferation and steroidogenesis in human adrenocortical cells, especially regarding aldosterone biosynthesis (8) (9) (10) (11) . Recently, it was reported that constitutive activation of Wnt/b-catenin signaling is the most frequent signal alteration found in 70% of APAs and therefore indicates that b-catenin plays an essential role in the control of aldosterone secretion and zona glomerulosa cell differentiation, with a direct impact on the pathogenesis of APAs (12) . Understanding the aberrant activation of the Wnt/b-catenin signaling pathway in APAs is important for the future development of therapeutic strategies.
miRNAs are short (~22 nucleotides) noncoding RNAs that can suppress the expression of protein-coding genes by targeting cognate mRNAs for translational repression or degradation (13, 14) . miRNAs are important regulators in various biological processes such as proliferation, apoptosis, and differentiation (15) . The results from several studies have indicated the importance of interactions between miRNAs and Wnt/b-catenin signaling in cancer development (16, 17) . However, the influence of miRNAs on tumorigenesis and aldosterone secretion in APAs has been studied rarely (18, 19) , especially regarding the modulation of the Wnt/b-catenin signaling in APAs.
Using a microarray-based approach, we identified a miRNA that was underexpressed in APA tumoral tissue and further investigated its role in connection with the Wnt/b-catenin pathway in aldosterone production and cell proliferation of APAs using an abundance of in vitro, in vivo, and clinical data correlations. Our findings could aid in the development of miRNA-based therapy for patients with APAs, especially those who could not undergo adrenalectomy.
Methods

Human subject identification and ascertainment
We identified 40 patients with APAs identified who had undergone adrenalectomy in accordance with the consensus guidelines of the Taiwan Society of Aldosteronism (4, 20-23) (Supplemental Table 1 ). APA tumoral and peritumoral adrenal tissue samples were obtained from the adrenalectomy surgical specimens from patients with APAs and immediately frozen in liquid nitrogen and stored at 280°C until use.
Ethical statement
The study was conducted in accordance with the requirements of the Human Tissue Act and approved by our institutional ethical committee (National Taiwan University Hospital approval no. 200611031R). All experimental procedures and protocols involving animals abided by the local institutional guidelines for animal care and were approved by the institutional animal care committee of National Taiwan University (Taipei, Taiwan).
miRNA microarray
Total RNA from APA tumoral tissues and their peritumoral adrenal tissue samples were converted to cDNA and labeled using FlashTag Biotin HSR Labeling Kits (Affymetrix, Santa Clara, CA) without amplification. The product was hybridized to Affymetrix Gene Chip miRNA 3.0 Arrays (Affymetrix) and scanned using an Affymetrix GCS3000 Gene Array Scanner according to the manufacturer's protocol.
Quantitative real-time PCR validation of miRNA and mRNA expression
For quantitative real-time PCR (qPCR) analysis of WNT5A, CYP11B2, and GAPDH transcripts, 1 mg of total RNA was reverse transcribed into cDNA using an oligdT and Thermoscript Reverse transcription (TaKaRa, Kyoto, Japan) and performed on a 7300 Sequence Detection System (Applied Biosystems, Foster City, CA) using SYBR green dye (Thermo Fisher Scientific, Vilnius, Lithuania).
For miR-203 expression analysis, the template RNA samples were adjusted to a concentration of 5 ng/mL using nucleasefree water and reverse transcribed using the Universal cDNA Synthesis Kit II (Exiqon, Vedbaek, Denmark). The miR-203 and U6 small nuclear RNA LNA ™ PCR primers (Exiqon, Vedbaek, Denmark) were used. The U6 small nuclear RNA was used as an endogenous control for normalization of miRNA expression levels.
Cell seeding and miRNA inhibitors, mimics, and small interfering RNA transfection
We used the human adrenocortical carcinoma cell line, HAC15, and primary culture of APA tumoral cells for the in vitro study. HAC15 cells were cultured in DMEM/F12 medium (Gibco, Carlsbad, CA). The primary APA cells were prepared from surgical adrenal adenoma tissues immediately after adrenalectomy, as previously reported (24) .
The cells were seeded into culture plates 24 hours before transfection. Transfection experiments were performed using miRNA inhibitors or miRNA mimics, small interfering RNA (siRNA), and the siRNA/miRNA negative control (Dharmacon, Lafayette, CO) in accordance with the DharmaFECT transfection reagent protocol (Dharmacon).
miRNA target prediction
The miRNA target prediction was performed using the miRSystem database, version 20160513 (available at:
http://mirsystem.cgm.ntu.edu.tw/), which integrates seven wellknown target gene prediction algorithms: Diana-microT, miRanda, miRBridge, PicTar, PITA, rna22, and Targetscan (25) .
Dual-luciferase reporter assay
The region 1475 to 4320 bp of the WNT5A 3 0 -untranslated region (UTR), including predicted binding sites for miR-203, was cloned into the pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega, Madison, WI) between the PmeI and SbfI restriction sites. An empty luciferase reporter vector was used as a mock control. HEK-293T cells were cultured in 24-well plates, and each well was transfected with 200 ng of the respective pMiRGLO 3 0 -UTR constructs and 50 nM miR-203 mimics or mimic negative control using Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol. The cells were harvested and assayed 48 hours after transfection. Luciferase activity was measured using the Dual-Glo Luciferase Assay System (Promega). Renilla luciferase activity was normalized to corresponding firefly luciferase activity. The experiments were performed in triplicate and repeated three times.
Animal studies C57BL/6 mice (8-to 10-week-old males) were purchased from the Laboratory Animal Center of National Taiwan University and prepared for laparotomy under standard preparation and procedures.
After exposing the bilateral adrenal gland, a 34-gauge cannula (Hamilton Company, Reno, NV) was introduced into the adrenal gland, and 5 mL of 10 mM miR-203 inhibitors or miRNA inhibitor negative control with Invivofectamine (Invitrogen) was injected into each side of the adrenal glands. Plasma samples were collected, and systolic blood pressure was measured at 24, 48, and 72 hours using the Visitech tail cuff system (BP 2000, Visitech System, Apex, NC) after injection.
Supplemental materials and methods
Further details of cell culture, qPCR, Western blotting, aldosterone measurement, cell proliferation, ELISA assay, and animal studies are provided in the Supplemental Methods.
Statistical analysis
Data were summarized as the mean 6 SEM from experiments repeated in triplicate. Comparisons of the two groups were analyzed using the t test with the Statistical Package for Social Sciences, version 12.0, software (IBM Corp., Armonk, NY), R software, version 3.2.2 (Free Software Foundation, Inc., Boston, MA), and MedCalc Statistical Software, version 15.11.3 (MedCalc Software BVBA, Ostend, Belgium; available at: https://www.medcalc.org). To reveal the effects of miR-203 on tumor size for individual patients, a generalized additive model (with spline) incorporating the subjectspecific (longitudinal) random effects was plotted with adjustment for other clinical parameters to predict the tumor size (23, 26) . Differences between groups at the same time point were compared using one-way ANOVA (Bonferroni correction). A probability P , 0.05 was considered to indicate statistical significance.
Results
Wnt/b-catenin signaling pathway-related miRNA profiling in APAs
We examined several Wnt/b-catenin signaling regulatory miRNAs that have been reported (16, 17) using a microarray-based expression analysis of 10 APA tissues and matched nontumoral adjacent tissues. The miRNA microarray showed that the expression levels of Wnt/b-catenin signaling regulatory miRNA candidates were significantly different between tumoral and peritumoral adrenal tissues in 10 patients with APAs (40% men; average age, 51.3 years; Table 1 ). Among these miRNAs, miR-375 (0.27-fold; P , 0.001) and miR-203 (0.65-fold; P , 0.001) were the two most significantly downregulated miRNAs. 
Expression of miR-203 in
Inhibition of miR-203 augmenting aldosterone levels in HAC15 cells
With the finding of decreased expression of miR-203 in APAs, we investigated whether downregulation of miR-203 in human adrenocortical cell lines (HAC15) could promote aldosterone production and/or tumorigenesis. We first confirmed that a specific miRNA inhibitor was able to effectively downregulate miR-203 expression in HAC15 cells (0.15 6 0.05-fold; P , 0.01; Supplemental Fig. 1 ). We then examined the expression of CYP11B2 via qPCR and Western blot. miR-203 inhibitors increased CYP11B2 mRNA (1.89 6 0.12-fold; P , 0.01) and protein (1.29 6 0.04-fold; P , 0.01) levels compared with the results of the negative control miR-203 directly acting on 3 0 -UTRs of WNT5A mRNA To further understand which protein or RNA executes its function, we used the bioinformatic algorithms (miRSystem database) for target gene predictions. The miR-203 target sequences within the 3 0 -UTRs of candidate mRNA were predicted by PicTar, miRanda, and DIANA. Among the candidates, WNT5A, an oncogene, was identified as one of the potential targets of miR-203 and selected for further analysis. The putative binding site of miR-203 within human WNT5A 3 0 -UTRs was a possible target [ Fig. 3(A) ]. A luciferase reporter-based cellular assay harboring the wild-type 3 0 -UTRs of WNT5A was used to monitor the regulation of these genes by miR-203. Our results showed that treatment with the miR-203 mimics substantially decreased the firefly luciferase activity compared with the negative control (2.05 6 0.22 vs 3.20 6 0.14; P , 0.01), suggesting that the 3 0 -UTRs of WNT5A were modulated by miR-203 [ Fig. 3(A) ].
We further explored the regulatory effect of miR-203 inhibitors on WNT5A gene expression. mRNA expression (2.16 6 0.21-fold; P , 0.01; Supplemental Fig. 3 ) and protein expression [1.26 6 0.05-fold; P , 0.01; Fig. 3(B) ] of WNT5A were markedly elevated in HAC15 cells treated with miR-203 inhibitors compared with those treated with the negative control.
To confirm whether upregulation of Wnt5a could lead to downstream signals, we analyzed the expression of ABC, CYP11B2, and cyclin D1. Compared with the control, the protein expression of ABC, CYP11B2, and cyclin D1 were all significantly increased in a dose-dependent manner after Wnt5a treatment for 48 hours in HAC15 cells [ Fig. 3(C) ]. Furthermore, regarding the cell line data of the effect of Wnt5a protein on cell proliferation after treatment with 100 ng/mL of recombinant Wnt5a protein, the proliferation of HAC15 cells was significantly increased, as measured using the CCK-8 assay [1.2-fold at 72 hours; P , 0.01; Fig. 3(D) ]. a We observed that miR-375 and miR-203 were two of the most significantly dysregulated Wnt/b-catenin pathway-related miRNAs in APAs (detailed comparison provided in the "Discussion" section). However, no statistically significant correlation was found between miR-375 and plasma aldosterone levels in patients with APAs (18) . Our unpublished data revealed that transfection of the miR-375 inhibitors did not increase the expression of active b-catenin in HAC15 cells. Therefore, we investigated the role of miR-203 in APAs.
b P values were corrected for multiple testing using the false discovery rate approach, and Q values (false discovery rate-corrected P values) ,0.05 were considered statistically significant.
The relative protein levels of Wnt5a, ABC, VSNL1 (visinin-like 1), and cyclin D1 in the APA tumoral tissues were all substantially increased compared with the respective levels in the peritumor adrenal tissue samples [ Fig. 3(E) ]. VSNL1 was used as an APA marker and was upregulated in APAs compared with normal adrenal tissues (5, 27) . From the data from adrenal vein sampling (AVS; n = 11), we also found that the level of plasma Wnt5a from the tumor side was greater than that on the contralateral side [0.30 6 0.05 ng/mL vs 0.19 6 0.04 ng/mL; P = 0.032; Fig. 3(F) ].
miR-203 inhibitors mediated aldosterone production by activation of the b-catenin pathway in adrenal cells
To demonstrate that the effect of miR-203 inhibitors on the aldosterone production is caused by activation of the b-catenin pathway, we cotreated HAC15 cells with b-catenin (CTNNB1) siRNA to knock down b-catenin. HAC15 cells transfected with miR-203 inhibitors showed increased CYP11B2 mRNA expression (1.58 6 0.12-fold; P , 0.01), which was suppressed after cotransfection with b-catenin siRNA [ Fig. 4(A) ]. Accordingly, the Western blot data showed that the miR-203 inhibitors enhanced the protein expression of ABC, b-catenin, and CYP11B2, which could also be attenuated by cotransfection with b-catenin siRNA [ Fig.  4(B) ]. Our results indicated that bcatenin plays an essential role for miR-203 inhibitor-enhanced aldosterone production.
Restoration of miR-203 suppressing cell proliferation and hypersecretion of aldosterone from primary APA cell culture
To evaluate the effect of miR-203 mimics on attenuation of target gene expression, aldosterone production, and cell proliferation of primary APA cells, we isolated the primary APA cell culture and transfected them with miR-203 mimics or miRNA mimic negative control. Western blot analysis revealed that the expression of Wnt5a, ABC, CYP11B2, and cyclin D1 were all significantly decreased after miR-203 mimics treatment compared with those of the miRNA mimic negative control treatment [ Fig. 5(A) ]. Furthermore, transfection with miR-203 mimics also showed reduced aldosterone levels in the culture supernatants [0.70 6 0.06-fold; P = 0.01; 
Preoperative plasma Wnt5a level predicting cure of hypertension after adrenalectomy
Receiver operating characteristic curves were plotted for plasma Wnt5a of 40 patients at APAs diagnosis (area under the curve, 0.694; P = 0.037) predicted the clinical cure of hypertension after adrenalectomy (28) . Patients with a preoperative plasma Wnt5a level of .0.133 ng/mL (the best cutoff point) had a significantly greater possibility of the cure of hypertension after adrenalectomy (61.1% vs 12.5%; P = 0.036; Supplemental Fig. 4 ).
Hyperaldosterone status did not alter the expression of miR-203
We further investigated whether the downregulation of miR-203 in APAs was the long-term effect of aldosterone exposure in vitro and in vivo. The plot was incorporated with the subject-specific (longitudinal) random effects of individual age, sex, aldosterone, potassium, and blood pressure to rule out confounder effects of these clinical parameters to predict the association constructed using the generalized additive model. Data presented as the mean 6 SEM (*P , 0.05).
Discussion
We designed and executed an abundance of both in vitro and in vivo experiments, with several lines of evidence and a variety of models, to confirm that attenuated miR-203 expression enhanced aldosterone production and tumorigenesis of aldosterone-producing adrenal cells via enhancement of the Wnt5a/b-catenin pathway. We also showed that the restoration of miR-203 (with miR-203 mimics) suppressed APA cell proliferation and decreased aldosterone production in the primary APA cell culture model. The preoperative plasma levels of Wnt5a could predict the cure of hypertension after adrenalectomy. The involvement of miR-203 in modulating Wnt5a/b-catenin signaling in the tumorigenesis processes makes it an important potential therapeutic target and a possible biomarker of APAs. The role of miR-203 in APA tumorigenesis and targeting Wnt5a/b-catenin is summarized in Fig. 5(D) .
From the miRNA microarray assay and qPCR study, we observed that miR-375 and miR-203 were two of the most significantly dysregulated Wnt/ b-catenin pathway-related miRNAs in APA tumoral tissues. Although miR-375 seemed to have the lowest relative miRNA level compared with peritumor adrenal tissue, no substantial correlation was found between miR-375 levels and plasma aldosterone levels in patients with APAs (18) . Our unreported data also revealed that transfection with miR-375 inhibitors did not increase the expression of ABC in HAC15 cells. Because we confirmed that reduced miR-375 expression did not increase the expression of ABC in HAC15 cells, we focused on miR-203 and found that attenuated miR-203 could be an underlying pathogenesis mechanism of APAs, because benign adenoma tumorigenesis and hypersecretion of aldosterone could be both triggered by this mechanism [ Fig. 5(D) ].
Therefore, we hypothesized that modulation of miR-203 could have potential as a target for the development of alternative therapeutic strategies for the treatment of patients with APAs in clinical practice. We also found that the underexpression of miR-203 in APAs was remarkably consistent, regardless of whether those adenomas were with or without somatic mutation, namely KCNJ5 (Supplemental Fig. 6 ). Further studies to elucidate the correlation and interactions of decreased miRNA expression and somatic mutations are needed.
Attenuated expression of miR-203 in APAs
Dysregulation of miRNA is involved in the initiation and progression of several human cancers, with strong evidence indicating that miRNAs can act as oncogenes or tumor suppressor genes (29) . We performed miRNA microarray analysis to validate the aberrant expression patterns of Wnt/b-catenin pathway-related miRNA in APAs. It has been reported that miR-203 silencing via DNA methylation could initiate tumorigenesis and upregulate Wnt and subsequent b-catenin expression in breast cancer cells (30) . Furthermore, activating miR-203 either epigenetically or by other methods has been reported to inhibit tumor invasion and metastasis (30, 31) . A recent study has reported that aldosterone might be able to alter the methylation status of rat miR-203 (rno-miR-203), promoting its hypermethylation and dysregulation on rno-miR-203 after acute kidney injury (32) . Nonetheless, our results showed found no substantial changes in miR-203 expression in both aldosterone-treated primary cultured adrenal cells and mouse adrenal gland after 28 days of aldosterone infusion, indicating no feedback on miR-203 expression via the aldosterone level.
Paracrine and local control of adrenal tumorigenesis
Increasing evidence has highlighted the importance of local mechanisms, such as paracrine and autocrine (in contrast to circulatory), that control aldosterone production and that are particularly relevant in the pathogenesis of PA (33) . Many of the cellular interactions within the tumor microenvironment support enhanced growth and dissemination of cancer cells (34) . Most notably, the emerging role of stromal cells in the establishment of a tumor-permissive environment has demonstrated great potential for therapeutic intervention. The results from our primary cultures of APAs were consistent with direct miR-203 interaction acting on the APA cells to regulate both aldosterone secretion and tumorigenesis (cell proliferation). We also documented that in vivo local injection of miR-203 inhibitors into the adrenal gland of wild-type mice induced hyperaldosterone status and consequent hypertension.
miR-203 targeting on Wnt5a
Our results suggested that activation of the Wnt signaling pathway is the mediator of the miR-203 response [ Fig. 5(D) ]. Exogenous application of Wnt5a increased activation of the b-catenin pathway and subsequent aldosterone production and tumorigenesis.
Aberrant activation of Wnt signaling has been implicated in the pathogenesis of several cancers and APAs (12, 35) . Our bioinformatics analysis indicated that miR-203 could target WNT5A for the first time to the best of our knowledge. WNT genes encode a family of 38 to 43 kDa glycoproteins, which are growth factors typically secreted by cells (36) . Wnt5a, a traditionally noncanonical Wnt ligand, has been implicated as a tumor suppressor or tumor promoter in the pathogenesis of different types of cancers (37, 38) . A wide variety of in vitro studies have suggested tumor-promoting properties of Wnt5a during multiple cellular processes, including growth, differentiation, epithelial-to-mesenchymal transition, angiogenesis, migration, and invasion, affecting both tumorigenic and nonmutant cells (39, 40) .
Unprecedentedly, we demonstrated the Wnt5a protein could activate discrete b-catenin signaling and also enhance aldosterone secretion by adrenal cells. Our results are also in agreement with those from previous reports showing that Wnt5a can activate the b-catenin pathway depending on the cell type and receptor context (41) (42) (43) (44) . Previous studies have reported that Wnt5a is capable of inducing cell proliferation in a variety of human cancers (45) (46) (47) (48) . However, we specifically demonstrated that Wnt5a enhanced the upregulation of cyclin D1 expression in adrenal cells and led to cell proliferation. Cyclin D1, which is a key regulator of cell cycle progression, is also a target gene of the Wnt/b-catenin pathway (49) .
Consistent with our in vitro findings, we also noted that the level of the secreted Wnt5a protein tended to be greater in the AVS blood sample from the tumor side compared with that from the contralateral side in patients with APAs during direct AVS. We documented that a greater plasma Wnt5a level could predict for a greater chance of hypertension cure after adrenalectomy. Because of the limited patient numbers in the present study, we could not achieve enough power to conclude that the Wnt5a levels during AVS are superior to the aldosterone/cortisol ratio in localizing the adenoma. Evaluation of Wnt5a protein expression to identify patients with APAs with favorable outcomes could thus be useful to avoid overtreatment in this group of patients. Patients with high Wnt5a protein levels in prostatic tumor cells have been found to have a lower risk of recurrence after radical prostatectomy (50) . These findings have demonstrated important implications for cancer metastasis (51) and have set the groundwork for further research on the relative pathway of the modulation involved in PA for both nodule formation and aldosterone hypersecretion.
Two facets of APAs modulated by miR-203
Recent data have shown that nodule formation and aldosterone hypersecretion can be associated in pathological adrenal glands and suggest a two-hit model for APA pathogenesis. Hypothetically, genetic alterations produce cell depolarization, increased cytoplasmic calcium activity, and increased CYP11B2 expression, leading to hyperaldosteronism. In addition, aberrant activations of a candidate signaling pathway (e.g., Wnt/b-catenin) causes imbalances in the process of cell proliferation in the adrenal gland, enhancing adenoma formation (33) . Several lines of evidence have suggested that the somatic mutations found in APAs not only increase aldosterone production, but also proliferation (33) . Our study has clearly demonstrated that attenuated expression of miR-203 could activate the Wnt5a/b-catenin pathway, trigger nodule formation, further augment steroidogenesis, and enhance hyperaldosteronism. Thus, evidence from the present study has shown that miR-203 might offer a common cornerstone of the two-hit model. The involvement of miR-203 modulated Wnt5a/b-catenin signaling in the tumorigenesis processes makes it an important potential therapeutic target and potential biomarker of APAs. Moreover, APA tumoral tissue samples, either with or without the KCNJ5 mutation, consistently showed greater attenuated miR-203 expression compared with the peritumor adrenal tissue. It is of great interest to ascertain whether modulating miR-203, specifically targeted via some novel drugs, could enable the use of personalized therapy for high-risk surgical patients with APAs.
Conclusion
Starting from miRNA microarray analysis and enriched with multiple lines of in vitro and in vivo evidence, our data support that attenuated miR-203 targets the aberrant expression of Wnt5a, which, in turn, modulates the activation of b-catenin and plays a very important role in APA tumorigenesis and hypersecretion of aldosterone. Higher plasma Wnt5a levels preoperatively could predict for the cure of hypertension after adrenalectomy. Our findings provide very important clues for further studies aimed at deciphering the role of miRNA in APA tumorigenesis and focusing on Wnt5a/b-catenin pathway in the targeted therapy for APAs.
